BOSTON--(BUSINESS WIRE)--908 Devices Inc, (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that several Tennessee drug task forces, law enforcement agencies and county sheriffs’ offices have chosen to implement the company’s MX908 handheld mass spectrometer to enhance the speed and efficiency of their drug identification processes.
The MX908 handheld mass spectrometer enables law enforcement agencies to identify drugs in both trace and bulk amounts quickly and accurately. With its unique ability to detect and analyze a wide range of chemical substances, the MX908 has become an invaluable tool for drug interdiction operations.
The pilot program aims to introduce the MX908 to law enforcement agencies across the state. Its main objective is to decrease the quantity of controlled substance samples that are sent to the laboratory for testing. This will be achieved by relocating the testing process to law enforcement locations, similar to how breath alcohol content is tested currently. As a result, overall wait times at the laboratory will be reduced, enabling forensic experts to prioritize and expedite the analysis of more crucial samples. Also, it is expected that the entire judicial process will encounter fewer delays due to reduced wait times for laboratory results.
Moreover, the MX908's swift and reliable drug identification capabilities enable law enforcement officers to ensure that individuals who are prosecuted for drug-related offenses enter drug treatment programs much sooner. By accelerating the identification process, the MX908 helps bridge the gap between law enforcement and rehabilitation, offering individuals a chance for timely intervention and support.
"We are delighted to partner with Tennessee state and local agencies in their tireless efforts to combat drug trafficking," said Kevin J. Knopp, CEO and Co-founder of 908 Devices. "The MX908 handheld mass spectrometer empowers law enforcement agencies and drug task forces to make faster and more informed decisions in the field, ultimately leading to safer communities and improved public health outcomes."
To learn more about the MX908 and 908 Devices, visit www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.
Forward Looking Statements
This press release includes “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding the expected uses and capabilities of the Company’s products. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on management’s current expectations and involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including the risks outlined under “Risk Factors” and elsewhere in the Company’s filings with the Securities and Exchange Commission which are available on the SEC's website at www.sec.gov. Additional information will be made available in the Company’s annual and quarterly reports and other filings that it makes from time to time with the SEC. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.
